Zürcher Nachrichten - 'Whole family cried': New gene therapy offers hope for deaf kids

EUR -
AED 4.081513
AFN 77.230118
ALL 99.042862
AMD 430.140447
ANG 2.003297
AOA 1032.870816
ARS 1069.272543
AUD 1.642244
AWG 2.001578
AZN 1.891198
BAM 1.953279
BBD 2.244384
BDT 132.82382
BGN 1.955628
BHD 0.418727
BIF 3214.74806
BMD 1.111216
BND 1.437883
BOB 7.68095
BRL 6.070127
BSD 1.111556
BTN 93.071223
BWP 14.684447
BYN 3.637804
BYR 21779.834762
BZD 2.240568
CAD 1.512215
CDF 3189.190401
CHF 0.941761
CLF 0.037483
CLP 1034.264491
CNY 7.869634
CNH 7.889245
COP 4656.273092
CRC 575.347202
CUC 1.111216
CUP 29.447226
CVE 110.581035
CZK 25.072369
DJF 197.485658
DKK 7.459843
DOP 66.72826
DZD 146.835789
EGP 53.922652
ERN 16.668241
ETB 129.160898
FJD 2.451457
FKP 0.846257
GBP 0.841741
GEL 2.980835
GGP 0.846257
GHS 17.457112
GIP 0.846257
GMD 76.673956
GNF 9612.018347
GTQ 8.597828
GYD 232.625627
HKD 8.660018
HNL 27.735577
HRK 7.55517
HTG 146.669414
HUF 394.304073
IDR 17004.939355
ILS 4.199563
IMP 0.846257
INR 93.080735
IQD 1455.693038
IRR 46787.751798
ISK 152.292299
JEP 0.846257
JMD 174.634647
JOD 0.787521
JPY 158.672729
KES 143.346323
KGS 93.744637
KHR 4522.64896
KMF 491.711705
KPW 1000.093823
KRW 1476.253041
KWD 0.338843
KYD 0.92633
KZT 532.423365
LAK 24568.987385
LBP 99509.397658
LKR 337.191845
LRD 216.687298
LSL 19.545888
LTL 3.281132
LVL 0.672163
LYD 5.283827
MAD 10.841857
MDL 19.313599
MGA 5067.145444
MKD 61.530629
MMK 3609.186415
MNT 3775.91212
MOP 8.922126
MRU 44.114338
MUR 50.948991
MVR 17.057703
MWK 1928.515872
MXN 21.403543
MYR 4.724337
MZN 71.006746
NAD 19.546773
NGN 1821.761212
NIO 40.848097
NOK 11.769856
NPR 148.920849
NZD 1.788863
OMR 0.42778
PAB 1.111546
PEN 4.195007
PGK 4.36469
PHP 62.030859
PKR 309.085048
PLN 4.273859
PYG 8666.738233
QAR 4.04566
RON 4.975249
RSD 117.057684
RUB 104.038142
RWF 1489.029519
SAR 4.170346
SBD 9.246166
SCR 14.965422
SDG 668.391412
SEK 11.34546
SGD 1.440891
SHP 0.846257
SLE 25.38829
SLL 23301.639441
SOS 634.504739
SRD 33.417049
STD 22999.928891
SVC 9.726099
SYP 2791.963614
SZL 19.545971
THB 37.115306
TJS 11.838011
TMT 3.900368
TND 3.36811
TOP 2.611133
TRY 37.856354
TTD 7.550121
TWD 35.523332
TZS 3027.441423
UAH 46.079379
UGX 4134.627366
USD 1.111216
UYU 45.549582
UZS 14162.448707
VEF 4025438.551901
VES 40.818578
VND 27363.69546
VUV 131.925803
WST 3.108586
XAF 655.129292
XAG 0.036848
XAU 0.000435
XCD 3.003117
XDR 0.823859
XOF 655.049687
XPF 119.331742
YER 278.192985
ZAR 19.512729
ZMK 10002.272396
ZMW 29.428495
ZWL 357.811118
  • CMSC

    0.0050

    25.055

    +0.02%

  • SCS

    0.1000

    14.11

    +0.71%

  • RIO

    -0.0100

    62.91

    -0.02%

  • CMSD

    -0.0300

    24.98

    -0.12%

  • NGG

    -0.3200

    70.05

    -0.46%

  • RBGPF

    3.5000

    60.5

    +5.79%

  • GSK

    -0.1300

    42.43

    -0.31%

  • BCE

    1.1000

    35.61

    +3.09%

  • AZN

    0.0500

    78.58

    +0.06%

  • JRI

    0.0600

    13.44

    +0.45%

  • BTI

    -0.1300

    37.88

    -0.34%

  • BCC

    1.8200

    137.06

    +1.33%

  • BP

    -0.1200

    32.43

    -0.37%

  • RYCEF

    0.0900

    6.55

    +1.37%

  • VOD

    0.0500

    10.23

    +0.49%

  • RELX

    -0.3900

    47.37

    -0.82%

'Whole family cried': New gene therapy offers hope for deaf kids
'Whole family cried': New gene therapy offers hope for deaf kids / Photo: Handout - Eye & Ent Hospital of Fudan University/AFP

'Whole family cried': New gene therapy offers hope for deaf kids

Zhu Yangyang babbles away like a typical happy three-year-old, calling out for "mama" and "papa" and accurately naming colors -- a remarkable achievement considering he was completely deaf just months ago.

Text size:

He is one of five children whose hearing was restored through a revolutionary new gene therapy in a clinical trial led by Chinese and American researchers, offering new hope for those born with a rare genetic mutation.

Yangyang's mother Chang Yiyi says she was moved to tears when she realized, around three weeks after the treatment last September, that Yangyang could hear her knocking on the door.

"I hid in a closet and called for him, and he still responded!" she told AFP in an interview from Shanghai.

The results of the study, published Wednesday in the prestigious journal Nature Medicine, mark the first time the procedure was performed on both ears. This led to significant improvements in speech perception and the ability to locate the source of sounds compared to treatment in just one ear.

"This is absolutely a turning point," Zheng-Yi Chen, the study's senior author at the Eaton-Peabody Laboratories at Mass Eye and Ear, told AFP, adding companies are now conducting clinical trials, including two in Boston, with the goal of moving towards regulatory approval.

"If the results hold, without any complications, I think in three to five years, it may be a medically approved product," he added.

- Rare mutation -

There are around 26 million people globally with genetic forms of deafness, with this particular therapy focusing on people born with a mutation of the OTOF gene -- roughly two to eight percent of inherited deafness cases.

This defect means they are unable to produce the protein otoferlin, which is needed for hair cells in the inner ear to convert sound vibrations into electrical signals that can be sent to the brain.

The treatment involves injecting a modified virus into the inner ear that smuggles in a working version of the OTOF gene, restoring hearing.

When they realized that Yangyang could hear for the first time, "the whole family cried" including Yangyang's mother and grandmother, said lead study author Yilai Shu of the Eye & ENT Hospital of Fudan University in Shanghai.

Chang, a 26-year-old homemaker, said that taking care of her son has become much easier since he began developing language skills, and the family soon hopes to move him from a speech rehabilitation school to traditional kindergarten.

- More genetic targets -

Shu led the research team that delivered the very first OTOF gene therapy in 2022, pioneering a treatment that has since been administered to more children around the world, including in the United States and the United Kingdom.

Treating both ears presented new challenges, he told AFP. Doubling the surgical procedures increased the risk of side effects.

However, careful dosing minimized the immune response, and only mild to moderate side effects -- like fever, vomiting and slightly elevated white cell counts -- were observed.

All five children, who ranged in age from one to 11, saw major improvements.

Two of them gained an ability to appreciate music -- a more complex acoustic signal -- and danced happily in videos recorded for the study.

Surprisingly, even the 11-year-old has gained some capacity to understand speech and talk, even though it was expected it would be too late for the brain to acquire this ability if it had never before perceived sound.

"That really shows our brain has a plasticity that maybe lasts much longer than we originally thought," said Chen. The clinical trial is ongoing, and the participants will be monitored for long-term follow up.

Meanwhile, Shu and Chen said they are working on further animal testing to develop treatments for other causes of genetic deafness, including those related to the GJB2 gene -- the most common cause of deafness present at birth.

O.Pereira--NZN